Zurich Insurance Released Life Sciences Risk Report
The report highlights significant liability coverage gaps for AI integration and digital health systems.
Updated on Oct. 5, 2026 in Healthcare
Live Poll
Do you trust that companies are held accountable when medical AI systems cause patient harm?
Zurich Insurance Group released a report titled Beyond 2030: The Future of Life Sciences that analyzes emerging risks in the medical sector. The document warns that traditional liability policies are currently failing to address dangers posed by AI systems and increasing cloud dependencies.
Why it matters
Scientific discovery in medicine is advancing faster than the risk management systems required to govern it. Liability lines have become increasingly blurred as integration across drug, app, and device ecosystems complicates legal accountability for bodily injury.
The report incorporated findings from interviews with 34 industry experts and a survey of 62 specialists. It highlights that the US healthcare sector recorded 460 ransomware attacks in 2025, while 75% of American hospitals suffered disruptions from a 2024 clearinghouse breach.
The players
Zurich Insurance Group
This is a Swiss-based multi-national insurance company that provides various financial and risk management services globally.
Food and Drug Administration
This federal agency is responsible for protecting public health by ensuring the safety and efficacy of medical devices and pharmaceuticals.
The details
The report notes that the upcoming EU Product Liability Directive, effective in December 2026, will classify software and AI systems as products subject to strict liability. Standard life sciences insurance policies currently lack specific provisions for AI-related injuries, leaving a widening gap for manufacturers.
Timeline
A major clearinghouse breach disrupted US hospital care throughout 2024.
The EU revised Product Liability Directive entered force in December 2024.
The FDA registry of AI-enabled medical devices reached 1,450 by the end of 2025.
The US healthcare sector recorded 460 ransomware attacks in 2025.
The EU Product Liability Directive takes effect in December 2026.
Market Landscape
The report aligns with the implementation of the EU Product Liability Directive, which mandates new standards for digital medical products. This shift forces life sciences companies to navigate a more stringent regulatory environment that directly challenges their legacy insurance models.
The potential for liability coverage gaps may eventually influence the cost and availability of advanced medical treatments. Patients and healthcare providers should anticipate stricter safety protocols as developers adjust their systems to meet new regulatory mandates.
The takeaway
Innovation in medical technology is creating complex new legal risks that traditional insurance policies have yet to account for. Stakeholders should review coverage parameters as regulatory bodies worldwide begin to categorize AI and software as primary sources of liability.
Further reading
For additional context on medical industry trends, explore our coverage of Healthcare.
Source note: This article includes information reported by Insurance Business.
Live Poll
Do you trust that companies are held accountable when medical AI systems cause patient harm?
